The latest expansion of ‘next-generation’ jabs.

---

AI-DESIGNED JAB

A new generation of AI-designed vaccine technology is showing “early promise” in what researchers describe as “a pivotal moment in the global fight against future pandemics”.

Scientists working with the University of Cambridge and international partners have developed an experimental vaccine designed using artificial intelligence to “identify common features across entire families of viruses”, rather than targeting a single strain.

The approach, reported in collaboration with multiple research, uses machine learning models trained on large datasets of coronavirus genetic sequences.

The AI system reportedly searches for ‘stable viral structures’ that are less likely to mutate, with the aim of ‘prompting a broad immune response’ capable of recognising not just current pathogens, but also related future ‘variants’.

According to early-stage findings, the vaccine has completed an initial Phase I clinical trial in humans and was reported to be “safe” and “well tolerated”.

Researchers say that participants ‘did not experience unexpected adverse effects’, allowing the programme to progress towards larger trials.

The key scientific ambition behind the work is to move away from the reactive model of vaccine development, which often requires updating vaccines as ‘viruses’ evolve.

Instead, the AI-designed approach aims to ‘anticipate viral evolution’ by targeting ‘conserved elements shared across virus families such as coronaviruses’.

‘Experts’ involved in the research suggest the implications could extend well beyond coronaviruses, with the same computational approach able to be applied to other ‘rapidly mutating pathogens’, such as influenza or haemorrhagic fever.

Media coverage on the news highlights optimism that this could mark a shift towards ‘universal vaccines’, reducing the need for frequent reformulation and annual campaigns.

It should be noted that Phase I trials involve relatively small numbers of participants and are not designed to determine how well a vaccine works in real-world conditions.

The next stage, typically Phase II trials, will involve larger groups – often hundreds of volunteers – to evaluate immune response strength and begin assessing efficacy.

Although, as we all know, trial stages can be manipulated and fudged to serve an agenda.

It should also be stressed that even if the AI approach supposedly proves ‘effective’ in controlled trials, real-world deployment would still require extensive regulatory review, manufacturing scale-up, and long-term monitoring.

Despite these caveats, the work is being widely viewed as an ‘important proof-of-concept’ for the use of artificial intelligence in immunology.

By accelerating the identification of vaccine targets and enabling broader-spectrum design, AI tools could reduce the time needed to respond to ‘emerging outbreaks’ in the future.

Just what we all need.

For now, the vaccine remains in the early stages of development, but scientists describe the results as a foundation for a potentially new class of ‘pandemic preparedness tools’.

Not just that, but it also serves as yet another branch in the ever-growing list of next-generation ‘vaccines’ that are in development, or have already been released.

What we once knew as a “vaccine” decades ago is very different in our 2026 world.

THE FUTURE OF VACCINES

Over the past decade, vaccine technology has shifted from a one-size-fits-all approach using entire pathogens, to a ‘flexible toolkit’ of ‘delivery innovations’ for ‘better precision’.

The traditional method that used whole weakened, or inactivated pathogens to get results, only target specific components of a ‘germ’, such as proteins.

Now, innovation has expanded beyond what is delivered to how it is delivered – and a plethora of new products are either set to hit our shores, or are already here.

The Future of Vaccines | FFT
RELATED PODCAST

For instance, scientists say vaccinations could soon be made ‘less painful’ by treating the skin with a vaccine-laden liquid, and then using ultrasound to push it into the body.

Yes, I am not making this stuff up.

‘Needle-free’ options like nasal sprays, skin patches, and high-pressure injection systems have also arrived in an attempt to ‘improve comfort and accessibility’.

Australia has become a testing ground for ‘needle-free vaccines’
RELATED FEATURE

Of course, modern advances like mRNA technology take this further by delivering genetic instructions that supposedly tell the body’s own cells to produce a ‘harmless’ piece of the pathogen, ‘training the immune system’ without ever needing to handle the real ‘virus’.

They also can, just like the AI-designed jab highlighted in this piece, be used to target a concoction of pathogens at once,bypassing the need for multiple vaccines.

Concerns over new six-in-one ‘super shot’ for babies
RELATED ARTICLE

‘Universal’ mRNA flu vaccine clinical trials begin
RELATED ARTICLE

Researchers are backed by large institutions and organisations for this research, encouraged to find ways to incorporate artificial intelligence into design processes like never before.

Queensland to develop a range of new vaccines at home with U.S. deal
RELATED ARTICLE

Australian scientists unveil ‘biological AI’ to speed up drug discovery
RELATED ARTICLE

With all of this craziness, it is no wonder that the Australian government is continuously expanding the definition of what a “vaccine” is, including products that offer ‘passive immunisation’ via temporary protection of ready-made antibodies.

Why Did Parliament Broaden the Legal Definition of “Vaccine”?
RELATED FEATURE

But do the people themselves know about all of these changes and advanced algorithms now shaping the health care system? I doubt it.

If vaccines themselves weren’t bad enough, folks, now we have AI designing them for trials.

How long before human oversight is also completely removed from this process?

Machines don’t have a conscious, so they wouldn’t even blink when told to deceptively pass a certain product through regulatory stages.

I, for one, will not be partaking in any AI jab injections – now or ever.

I hope that all TOTT News readers have the same mentality and approach.

What are your thoughts on this news?

Be sure to leave a comment down below!

---

---

KEEP UP-TO-DATE

For more TOTT News:

Facebook — Facebook.com/TOTTNews

YouTube — YouTube.com/TOTTNews

Instagram — Instagram.com/TOTTNews

Twitter — Twitter.com/EthanTOTT

Rumble — Rumble.com/c/TOTTNews

Bitchute — Bitchute.com/channel/TOTTNews

Gab — Gab.com/TOTTNews

---

---